| Titre : | C-reactive protein and the risk of incident colorectal Cancer. (2004) |
| Auteurs : | Thomas-P ERLINGER ; Kathy-J HELZLSOUER ; Elizabeth-A PLATZ ; Nader RIFAI ; Johns Hopkins Bloomberg School of Public Health. Department of Epidemiology. Baltimore. MD. USA ; Johns Hopkins Medical Institutions. Department of Medicine. Baltimore. MD. USA |
| Type de document : | Article |
| Dans : | JAMA - Journal of the american medical association (vol. 291, n° 5, 2004) |
| Pagination : | 585-590 |
| Langues: | Anglais |
| Mots-clés : | Facteur risque ; Risque ; Homme ; Epidémiologie ; Inflammation ; Appareil digestif [pathologie] ; Intestin [pathologie] |
| Résumé : | [BDSP. Notice produite par INIST-CNRS NR0xkfQ8. Diffusion soumise à autorisation]. Context : Inflammation may play a role in the pathogenesis of colorectal cancer ; however, epidemiological evidence supporting this hypothesis in average-risk persons is sparse. Objective : To determine the risk of incident colon and rectal cancer associated with elevated baseline plasma concentrations of C-reactive protein (CRP). Design, Setting, and Participants : Prospective, nested case-control study of a cohort of 22887 adults (>18 years and Washington County, Maryland, residents) enrolled between May and October 1989 and followed up through December 2000. A total of 172 colorectal cancer cases were identified through linkage with the Washington County and Maryland State Cancer registries. Up to 2 controls (n=342) were selected from the cohort for each case and matched by age, sex, race, and date of blood draw. Main Outcome Measure Odds ratio (OR) of incident colon and rectal cancer. Results : Plasma CRP concentrations were higher among all colorectal cases combined than controls (median CRP, 2.44 vs 1.94 mg/L ; P=01). The highest concentration was found in persons who subsequently developed colon cancer vs matched controls (median CRP, 2.69 vs 1.97 mg/L ; P<. 001). Among rectal cancer cases, CRP concentrations were not significantly different from controls (median CRP, 1.79 vs 1.81 mg/L ; P=32). The risk of colon cancer was higher in persons in the highest vs lowest quartile of CRP (OR, 2.55 ; 95% confidence interval [CI], 1.34-4.88 ; P for trend=002). In nonsmokers, the corresponding association was stronger (OR, 3.51 ; 95% CI, 1.64-7.51 ; P for trend<. 001). A 1-SD increase in log CRP (1.02 mg/L) was associated with an increased risk of colon cancer after adjusting for potential confounders and excluding cases occurring within 2 years of baseline (OR, 1.35 ; 95% Cl, 1.05-1.74) or excluding those with late-stage colon cancer at the time of diagnosis (OR, 1.38 ; 95% Cl, 0.99-1.91). Conclusions : Plasma CRP concentrations are elevated among persons who subsequently develop colon cancer. These data support the hypothesis that inflammation is a risk factor for the development of colon cancer in average-risk individuals. |
Service Documentation EHESP
Me connecter
PORTAIL DOCUMENTAIRE
École des hautes études en santé publique
Catalogue
Multi-bases
Accueil
Sélection de la langue
Adresse
Service Documentation EHESPBibliothèque Rennes Avenue du Professeur Léon Bernard – CS 74312 – 35043 Rennes Cedex Bibliothèque MSSH Paris 20 avenue George Sand - 93210 La Plaine Saint-Denis
France
Bibliothèque Rennes : 02 99 02 29 50 Bibliothèque MSSH Paris : 02 99 02 24 50
contact